Perfil dos relatos de suscetibilidade à hipertermia maligna confirmados com teste de contratura muscular no Brasil

Pereira, 1975, Hipertermia maligna durante cirurgia de estapedectomia, Braz J Anesthesiol., 25, 3 2008, 1 Rosenberg H, Sambuughin N, Riazi S, et al. Malignant Hyperthermia Susceptibility. 2003 Dec 19 Updated 2013 Jan 31. In: Pagon RA, Adam MP, Ardinger HH, et al., (eds.). GeneReviews® Internet. Seattle (WA): University of Washington, Seattle; 1993‐2016. Disponível em: http://www.ncbi.nlm.nih.gov/books/NBK1146. Larach, 2008, Cardiac arrests and deaths associated with malignant hyperthermia in North America from 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States, Anesthesiology., 108, 603, 10.1097/ALN.0b013e318167aee2 Larach, 2010, Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006, Anesth Analg., 110, 498, 10.1213/ANE.0b013e3181c6b9b2 Sambuughin, 2009, The ryanodine receptor type 1 gene variants in African American men with exertional rhabdomyolysis and malignant hyperthermia susceptibility, Clin Genet., 76, 564, 10.1111/j.1399-0004.2009.01251.x Stamm, 2008, Native american myopathy: congenital myopathy with cleft palate, skeletal anomalies, and susceptibility to malignant hyperthermia, Am J Med Genet., 146A, 1832, 10.1002/ajmg.a.32370 Wang, 2010, Clinical features and diagnosis for Chinese cases with malignant hyperthermia: a case cluster from 2005 to 2007, Chin Med J., 123, 1241 Migita, 2007, Fulminant‐type malignant hyperthermia in Japan: cumulative analysis of 383 cases, J Anesth., 21, 285, 10.1007/s00540-006-0495-5 Monnier, 2002, Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility, Anesthesiology., 97, 1067, 10.1097/00000542-200211000-00007 Vainzof, 2000, Does the A3333G mutation in the CACNL1A3 gene, detected in malignant hyperthermia, also occur in central core disease?, Genet Test., 4, 383, 10.1089/109065700750065135 Muniz, 2003, Screening for mutations in the RYR1 gene in families with malignant hyperthermia, J Mol Neurosci., 21, 35, 10.1385/JMN:21:1:35 Kossugue, 2007, Central core disease due to recessive mutations in RYR1 gene: is it more common than described?, Muscle Nerve., 35, 670, 10.1002/mus.20715 Ellis, 1984, A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility, Br J Anaesth., 56, 1267, 10.1093/bja/56.11.1267 Larach, 1989, Standardization of the caffeine halothane muscle contracture test, Anesth Analg., 69, 511, 10.1213/00000539-198910000-00015 Resolução SS – 23, de 27 de fevereiro de 2004. D.O.E.; Poder Executivo, Seção I, São Paulo, 114(39), p.17‐19, sábado, 28/02/2004. Teixeira, 2005, Hipertermia Maligna, Legislação no Estado de São Paulo, Revista Neurociências., 13, 21‐5 Klingler, 2014, Functional and genetic characterization of clinical malignant hyperthermia crises: a multi‐centre study, Orphanet J Rare Dis., 9, 8, 10.1186/1750-1172-9-8 Riazi, 2014, Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands, Anesth Analg., 118, 381, 10.1213/ANE.0b013e3182937d8b Glahn, 2010, Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group, Br J Anaesth., 105, 417, 10.1093/bja/aeq243 Neto, 1992, Hipertermia maligna: retrato brasileiro, Braz J Anesthesiol., 42, 395 Barbier, 2009, A case of malignant hyperthermia arising five hours after the beginning of anaesthesia with sevoflurane and after five uneventful surgical procedures, Ann Fr Anesth Reanim., 28, 983, 10.1016/j.annfar.2009.09.008 Santos, 2017, Idiopathic hyperCKemia and malignant hyperthermia susceptibility, Can J Anaesth., 64, 1202, 10.1007/s12630-017-0978-x Lavezzi, 2013, Case report: Death in the emergency department: an unrecognized awake malignant hyperthermia‐like reaction in a six‐year‐old, Anesth Analg., 116, 420, 10.1213/ANE.0b013e3182768f99 Dlamini, 2013, Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis, Neuromuscul Disord., 23, 540, 10.1016/j.nmd.2013.03.008 Silva, 2000, Susceptibilidade à hipertermia maligna em três pacientes com síndrome maligna por neurolépticos, Arq Neuro‐Psiquiatr., 58, 713, 10.1590/S0004-282X2000000400018 Broman, 2015, Malignant hyperthermia, a Scandinavian update, Acta Anaesthesiol Scand., 59, 951, 10.1111/aas.12541 Silva, 2013, Malignant hyperthermia in Brazil: analysis of hotline activity in 2009, Braz J Anesthesiol., 63, 20, 10.1590/S0034-70942013000100002